Interventions for managing medication-related osteonecrosis of the jaw
Interventions for managing medication-related osteonecrosis of the jaw
Cochrane Review
8 SoF Entries
Summary of Findings
Key results and quality assessments using GRADE methodology
| Outcome | Effect | Participants | Studies | Certainty |
|---|---|---|---|---|
|
Aesthetic condition change related to patient's opinion
SCTG + CAF |
nan | - | - | Not assessed |
|
Sites with complete root coverage
SCTG + CAF |
0.43 | - | - | Not assessed |
|
Gingival recession change
SCTG + CAF |
-0.36 | - | - | Not assessed |
|
Clinical attachment level change
SCTG + CAF |
-0.53 | - | - | Not assessed |
|
Keratinized tissue change
SCTG + CAF |
-0.59 | - | - | Not assessed |
|
Gingival recession depth change
CAF |
0.61 | - | - | Not assessed |
|
Keratinized tissue width change
CAF |
0.28 | - | - | Not assessed |
|
Clinical attachment change
SCTG + CAF |
-0.25 | - | - | Not assessed |
GRADE Certainty of Evidence:
High
Very confident in the effect estimate
Moderate
Moderately confident in the effect estimate
Low
Limited confidence in the effect estimate
Very Low
Very little confidence in the effect estimate
Review Information
| Review ID: | CD007161 |
| Outcomes: | 8 assessed |
Related Content
Evidence Quality Distribution:
Not assessed:
8